Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Accenture
Covington
McKesson
Moodys
Julphar
Novartis
Teva
Mallinckrodt
Harvard Business School

Generated: August 17, 2017

DrugPatentWatch Database Preview

TRANEXAMIC ACID Drug Profile

« Back to Dashboard

What is the patent landscape for Tranexamic Acid, and when can generic versions of Tranexamic Acid launch?

Tranexamic Acid is a drug marketed by Micro Labs, Emcure Pharms Ltd, Mylan, Akorn, Aurobindo Pharma Ltd, Acic Fine Chems, Gland Pharma Ltd, Amneal Pharms Co, North Creek Pharms, Amerigen Pharms Ltd, Mylan Institutional, X-gen Pharms Inc, Luitpold, Apotex Inc, Actavis Labs Fl Inc, and Fresenius Kabi Usa. and is included in seventeen NDAs.

The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.

Summary for Tradename: TRANEXAMIC ACID

Patents:0
Applicants:16
NDAs:17
Suppliers / Packagers: see list18
Bulk Api Vendors: see list123
Clinical Trials: see list4,857
Patent Applications: see list3,133
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRANEXAMIC ACID at DailyMed

Pharmacology for Tradename: TRANEXAMIC ACID

Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Micro Labs
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION206713-001Jun 27, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION207239-001Feb 13, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION206634-001Jun 9, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION202373-001Nov 17, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
TRANEXAMIC ACID
tranexamic acid
INJECTABLE;INJECTION208840-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Dow
Moodys
US Army
UBS
Federal Trade Commission
Johnson and Johnson
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot